These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7852485)

  • 1. Therapeutic controversies. Radioiodine therapy does not aggravate Graves' ophthalmopathy.
    Gorman CA
    J Clin Endocrinol Metab; 1995 Feb; 80(2):340-2. PubMed ID: 7852485
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic controversies. Radioiodine may be bad for Graves' ophthalmopathy, but...
    Pinchera A; Bartalena L; Marcocci C
    J Clin Endocrinol Metab; 1995 Feb; 80(2):342-5. PubMed ID: 7852486
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative Efficacy of Four Treatments in Patients with Graves' Disease: a Network Meta-analysis.
    Ren Z; Qin L; Wang JQ; Li Y; Li J; Zhang RG
    Exp Clin Endocrinol Diabetes; 2015 May; 123(5):317-22. PubMed ID: 25988881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic controversies. Summation, commentary, and overview: concerns over aggravation of Graves' ophthalmopathy by radioactive iodine treatment and the use of retrobulbar radiation therapy.
    Wartofsky L
    J Clin Endocrinol Metab; 1995 Feb; 80(2):347-9. PubMed ID: 7852488
    [No Abstract]   [Full Text] [Related]  

  • 5. Therapeutic controversies. Retro-orbital radiation and radioactive iodide ablation of the thyroid may be good for Graves' ophthalmopathy.
    DeGroot LJ; Gorman CA; Pinchera A; Bartalena L; Marcocci C; Wiersinga WM; Prummel MF; Wartofsky L; Marocci C [corrected to Marcocci C]
    J Clin Endocrinol Metab; 1995 Feb; 80(2):339-40. PubMed ID: 7677823
    [No Abstract]   [Full Text] [Related]  

  • 6. Radioiodine therapy and Graves' ophthalmopathy.
    Bartalena L
    Nucl Med Commun; 2002 Nov; 23(11):1143-5. PubMed ID: 12411845
    [No Abstract]   [Full Text] [Related]  

  • 7. Radioiodine and Graves' ophthalmopathy reconsidered.
    Noury AM; Stanford MR; Graham EM
    Nucl Med Commun; 2001 Nov; 22(11):1167-9. PubMed ID: 11606880
    [No Abstract]   [Full Text] [Related]  

  • 8. Does radioiodine cause the ophthalmopathy of Graves' disease?
    McDougall IR
    Nucl Med Commun; 1993 Feb; 14(2):79-81. PubMed ID: 8429998
    [No Abstract]   [Full Text] [Related]  

  • 9. Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy.
    Bartalena L; Marcocci C; Bogazzi F; Manetti L; Tanda ML; Dell'Unto E; Bruno-Bossio G; Nardi M; Bartolomei MP; Lepri A; Rossi G; Martino E; Pinchera A
    N Engl J Med; 1998 Jan; 338(2):73-8. PubMed ID: 9420337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Graves' ophthalmopathy in patients treated with radioiodine 131-I.
    Bałdys-Waligórska A; Gołkowski F; Kusnierz-Cabala B; Buziak-Bereza M; Hubalewska-Dydejczyk A
    Endokrynol Pol; 2011; 62(3):214-9. PubMed ID: 21717402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine ophthalmopathy and radioiodine therapy.
    Karlsson FA
    Acta Oncol; 2006; 45(8):1046-50. PubMed ID: 17118837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Graves' ophthalmopathy and 131I therapy.
    Marcocci C; Bartalena L; Tanda ML; Manetti L; Dell'Unto E; Mazzi B; Rocchi R; Barbesino G; Pinchera A
    Q J Nucl Med; 1999 Dec; 43(4):307-12. PubMed ID: 10731781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (131)I and thyroid-associated ophthalmopathy.
    Rasmussen AK; Nygaard B; Feldt-Rasmussen U
    Eur J Endocrinol; 2000 Aug; 143(2):155-60. PubMed ID: 10913933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine therapy and Graves' ophthalmopathy.
    Bartalena L; Marcocci C
    Thyroid; 1996 Jun; 6(3):253. PubMed ID: 8837336
    [No Abstract]   [Full Text] [Related]  

  • 15. [Paradoxical effect of radioiodine therapy in functional thyroid autonomy and mild immunothyropathy].
    Dunkelmann S; Rudolph F; Prillwitz A; Groth P; Schümichen C
    Nuklearmedizin; 1998 Jan; 37(1):23-9. PubMed ID: 9467166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine therapy and Graves' ophthalmopathy.
    Spitzweg C; Rossmüller B; Heufelder AE
    Thyroid; 1998 Dec; 8(12):1193. PubMed ID: 9920377
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioiodine associated de novo Graves' opthalmopathy in an Asian cohort.
    Tay WL; Tong AKT; Hui KYD; Tang YLC; Chng CL
    Hell J Nucl Med; 2017; 20(3):227-231. PubMed ID: 29177260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radioiodine therapy and thyroid-associated orbitopathy: risk factors and preventive effects of glucocorticoids.
    Dietlein M; Dederichs B; Weigand A; Schicha H
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 5():S190-4. PubMed ID: 10614920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in graves' ophthalmopathy after radioiodine and anti-thyroid drug treatment of Graves' disease from 2 prospective, randomized, open-label, blinded end point studies.
    Chen DY; Schneider PF; Zhang XS; Luo XY; He ZM; Chen TH
    Exp Clin Endocrinol Diabetes; 2014 Jan; 122(1):1-6. PubMed ID: 24203649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Graves' disease nd toxic nodular goiter--radioiodine therapy].
    Schicha H; Dietlein M
    Nuklearmedizin; 2002 Apr; 41(2):63-70. PubMed ID: 11989300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.